Dr. Denlinger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3025 Chemical Rd
Suite 100
Plymouth Meeting, PA 19462Phone+1 267-622-6654- Is this information wrong?
Summary
- Provides oversight to NCCN’s Oncology Research Program and select Compendia products. Participates in NCCN policy and global initiatives. Practicing clinician with part-time voluntary faculty appointment at Fox Chase Cancer Center.
Education & Training
- Temple University HospitalFellowship, Hematology and Medical Oncology, 2004 - 2007
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2001 - 2004
- Rutgers New Jersey Medical SchoolClass of 2001
Certifications & Licensure
- PA State Medical License 2004 - 2024
- NY State Medical License 2002 - 2004
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow American College of Physicians
Clinical Trials
- Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment Start of enrollment: 2008 Jul 01
- Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Start of enrollment: 2009 Oct 28
- Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer Start of enrollment: 2011 Apr 27
- Join now to see all
Publications & Presentations
PubMed
- Empowering Lung Cancer Survivors in Post-Treatment Survivorship Care Using Participatory Action Research.Kelly Filchner, Rick Zoucha, Joan Such Lockhart, Crystal S Denlinger> ;Oncology Nursing Forum. 2023 Aug 17
- 2 citationsA phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors.Matthew Zibelman, Alexander W MacFarlane 4th, Kimberly Costello, Thomas McGowan, John O'Neill, Rutika Kokate, Hossein Borghaei, Crystal S Denlinger, Efrat Dotan, Danie...> ;Nature Communications. 2023 Jul 27
- 2 citationsThe effects of exercise and diet on oxidative stress and telomere length in breast cancer survivors.Justin C Brown, Kathleen Sturgeon, David B Sarwer, Andrea B Troxel, Angela M DeMichele, Crystal S Denlinger, Kathryn H Schmitz> ;Breast Cancer Research and Treatment. 2023 May 1
- Join now to see all
Journal Articles
- KRASG12C Inhibition with Sotorasib in Advanced Solid TumorsDavid S Hong, Marwan G Fakih, Gregory A Durm, Geoffrey I Shapiro, Gerald S Falchook, Adrian Sacher, Crystal S Denlinger, John C Krauss, Andrew L Coveler, Suresh S Rama..., The New England Journal of Medicine
Authored Content
- Cardiovascular Toxicity in Cancer Survivors: Current Guidelines and Future DirectionsJune 2018
Press Mentions
- New Resource for Survivors from NCCN Helps Guide Life After Cancer Diagnosis and TreatmentJanuary 5th, 2021
- More Than Half of Cancer Survivors Don’t Abstain from AlcoholJanuary 14th, 2020
- Better Doctor/Patient Communication Means Better Outcomes in Cancer Care, According to a Report in JNCCNAugust 23rd, 2018
- Join now to see all
Grant Support
- NCCN Foundation Young Investigator AwardNCCN Foundation2012–2014
Committees
- Chair, NCCN Survivorship Guidelines Panel 2012 - Present
- Member, Chemotherapy subcommittee, NCCN Esophagogastric Cancers Guidelines Panel 2009 - Present
- Member, NCI Esophagogastric Task Force 2012 - 2013
Professional Memberships
- Member
- Member
Hospital Affiliations
- Temple University HospitalPhiladelphia, Pennsylvania
- Fox Chase Cancer CenterPhiladelphia, Pennsylvania
- Temple University Hospital - Jeanes CampusPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: